Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis

Journals

1. Klara K, Kim J, Ross J. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines. Journal of General Internal Medicine 2018;33(5):651 View
2. Krishna A, Thompson T. Misinformation About Health: A Review of Health Communication and Misinformation Scholarship. American Behavioral Scientist 2021;65(2):316 View
3. Ju I. The effects of advertising skepticism in consumer prescription drug advertising. International Journal of Pharmaceutical and Healthcare Marketing 2017;11(4):395 View
4. Aikin K, Sullivan H, Dolina S, Lynch M, Squiers L. Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis. Journal of Medical Internet Research 2017;19(7):e225 View
5. Ju I. Thinking about fair balance: how prescription drug advertising disclosure prominence works?. International Journal of Pharmaceutical and Healthcare Marketing 2017;11(1):2 View
6. Giombi K, Thompson J, Wines C, Haughney R, Sullivan H, Betts K. A scoping review of empirical research on prescription drug promotion. Research in Social and Administrative Pharmacy 2023;19(6):859 View
7. Park S, Hill K, Yun G, Friedman S, Coppes M. Analysis of Direct-To-Consumer Healthcare Service Advertisements on Television: An Application of the Patient Expectation Framework. Health Communication 2023;38(10):2067 View

Books/Policy Documents

1. Weisenbach R. Institutionelle Korruption und Arzneimittelvertrieb. View